Published November 4, 2021 | Version v1
Project deliverable Open

CAPABLE D7.4: Second Interim Usability and Acceptability Evaluation Report

  • 1. Universidad Politécnica de Madrid, Spain
  • 2. University of Pavia, Italy
  • 3. Academic Medical Center Amsterdam (AMC), The Netherlands
  • 4. Bitsens, Lithuania
  • 5. Istituti Clinici Scientifici Maugeri (ICS Maugeri), Italy
  • 6. Netherlands Cancer Institute (NKI), The Netherlands
  • 7. Aimac, Italy


This document presents the results of the second evaluation and validation iteration of the CAPABLE prototypes as defined in previous deliverable D7.1. In this validation process, an updated version of the WP6 prototype has been evaluated
applying the two methods presented in D7.1:

  • Interviews with patients and relatives. These interviews aimed to collect feedback from the end-users of the Patient App: melanoma and kidney cancer patients during the treatment phase. Given the broader applicability of the app to any type of cancer patient, this iteration included also other types of oncological patients, cancer survivors (treatment finished since no more than 2 years), and experts in patients’ needs, such as caregivers. Overall, 17 patients and 2 caregivers have been interviewed.
  • Interviews with healthcare professionals (HCPs). These interviews aimed to collect overall feedback about both doctors’ and patients’ solutions, understand if the clinical and patients’ needs are covered, and revise the core functionalities that have been proposed in the current prototype. A total of 11 health professionals have been interviewed.

We present the results of the 2 executed studies. The protocols of each study are attached in the annex. The document also presents the general conclusions from these validation activities and the next steps to follow in the future developments in order to satisfy the user experience needs found in this process.


This deliverable is a part of a project receiving funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 875052



Additional details


CAPABLE – CAncer PAtients Better Life Experience 875052
European Commission